Digital quantitation of HCC-associated stem cell markers and protein quality control factors using tissue arrays of human liver sections.

[1]  H. Liu,et al.  Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form. , 2014, Experimental and molecular pathology.

[2]  L. Rodrigo,et al.  Toll‐like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  M. A. Mohammed,et al.  Regulation of Cancer Stem Cell Marker (CD133) by Transforming Growth Factor Beta in Hepatocellular Carcinoma , 2014 .

[4]  S. Dooley,et al.  Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells. , 2013, The Journal of clinical investigation.

[5]  Haiyang Xie,et al.  G Protein-Coupled Receptor 87 (GPR87) Promotes the Growth and Metastasis of CD133+ Cancer Stem-Like Cells in Hepatocellular Carcinoma , 2013, PloS one.

[6]  S. French,et al.  Mallory-Denk bodies form when EZH2/H3K27me3 fails to methylate DNA in the nuclei of human and mice liver cells. , 2012, Experimental and molecular pathology.

[7]  K. Machida,et al.  Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus , 2012, Journal of gastroenterology and hepatology.

[8]  Manuel Serrano,et al.  Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells , 2011, Cell cycle.

[9]  Haojie Huang,et al.  Phosphorylation of EZH2 by CDK1 and CDK2 , 2011, Cell cycle.

[10]  Lu Gan,et al.  Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2 , 2010, Nature Cell Biology.

[11]  M. Zern,et al.  Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. , 2010, Experimental and molecular pathology.

[12]  S. French,et al.  The identification of stem cells in human liver diseases and hepatocellular carcinoma. , 2010, Experimental and molecular pathology.